Ami Citri

Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy.

The deaf and the dumb: the biology of ErbB-2 and ErbB-3.

Polar expression of ErbB-2/HER2 in epithelia. Bimodal regulation by Lin-7.

The achilles heel of ErbB-2/HER2: regulation by the Hsp90 chaperone machine and potential for pharmacological intervention.

Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding.

LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.

Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation.

Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling.

Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity.

Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1.

Hsp90 recognizes a common surface on client kinases.

Hsp90 increases LIM kinase activity by promoting its homo-dimerization.

Geldanamycins trigger a novel Ron degradative pathway, hampering oncogenic signaling.

EGF-ERBB signalling: towards the systems level.

A module of negative feedback regulators defines growth factor signaling.

A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration.

Synaptic plasticity: multiple forms, functions, and mechanisms.

N-methyl-D-aspartate receptor- and metabotropic glutamate receptor-dependent long-term depression are differentially regulated by the ubiquitin-proteasome system.

Calcium binding to PICK1 is essential for the intracellular retention of AMPA receptors underlying long-term depression.

Induction of human neuronal cells by defined transcription factors.

Comprehensive qPCR profiling of gene expression in single neuronal cells.

Genome-wide association study of multiplex schizophrenia pedigrees.